| Neurostimulation for Parkinson's disease with early motor complications WMM Schuepbach, J Rau, K Knudsen, J Volkmann, P Krack, ... New England Journal of Medicine 368 (7), 610-622, 2013 | 1615 | 2013 |
| A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in Europe N Abbas, CB Lücking, S Ricard, A Dürr, V Bonifati, G De Michele, ... Human molecular genetics 8 (4), 567-574, 1999 | 716 | 1999 |
| Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study C Brefel‐Courbon, P Payoux, C Thalamas, F Ory, I Quelven, F Chollet, ... Movement disorders: official journal of the Movement Disorder Society 20 (12 …, 2005 | 454 | 2005 |
| Limitations of current Parkinson's disease therapy O Rascol, P Payoux, F Ory, JJ Ferreira, C Brefel‐Courbon, JL Montastruc Annals of Neurology: Official Journal of the American Neurological …, 2003 | 436 | 2003 |
| Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, F Ory-Magne, ... Journal of Neurology, Neurosurgery & Psychiatry 78 (10), 1140-1142, 2007 | 284 | 2007 |
| Longitudinal analysis of impulse control disorders in Parkinson disease JC Corvol, F Artaud, F Cormier-Dequaire, O Rascol, F Durif, ... Neurology 91 (3), e189-e201, 2018 | 269 | 2018 |
| Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease F Courbon, C Brefel‐Courbon, C Thalamas, MJ Alibelli, I Berry, ... Movement disorders: official journal of the Movement Disorder Society 18 (8 …, 2003 | 250 | 2003 |
| Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo … C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ... The lancet neurology 11 (7), 589-596, 2012 | 223 | 2012 |
| Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy C Brefel‐Courbon, P Payoux, F Ory, A Sommet, T Slaoui, G Raboyeau, ... Annals of neurology 62 (1), 102-105, 2007 | 207 | 2007 |
| α-Synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms P Ibáñez, S Lesage, S Janin, E Lohmann, F Durif, A Destée, AM Bonnet, ... Archives of neurology 66 (1), 102-108, 2009 | 191 | 2009 |
| Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene R Vidal, B Ghetti, M Takao, C Brefel-Courbon, E Uro-Coste, BS Glazier, ... Journal of Neuropathology & Experimental Neurology 63 (4), 363-380, 2004 | 190 | 2004 |
| Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease O Rascol, I Arnulf, H Peyro‐Saint Paul, C Brefel‐Courbon, M Vidailhet, ... Movement disorders: official journal of the Movement Disorder Society 16 (4 …, 2001 | 181 | 2001 |
| Orthostatic hypotension in patients with Parkinson’s disease: pathophysiology and management JM Senard, C Brefel-Courbon, O Rascol, JL Montastruc Drugs & aging 18, 495-505, 2001 | 169 | 2001 |
| Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial F Ory-Magne, JC Corvol, JP Azulay, AM Bonnet, C Brefel-Courbon, ... Neurology 82 (4), 300-307, 2014 | 165 | 2014 |
| Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts G Liu, JJ Locascio, JC Corvol, B Boot, Z Liao, K Page, D Franco, K Burke, ... The Lancet Neurology 16 (8), 620-629, 2017 | 164 | 2017 |
| Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial … E Lhommée, L Wojtecki, V Czernecki, K Witt, F Maier, L Tonder, ... The Lancet Neurology 17 (3), 223-231, 2018 | 163 | 2018 |
| Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects M Periquet, CB Lücking, JR Vaughan, V Bonifati, A Dürr, G De Michele, ... The American Journal of Human Genetics 68 (3), 617-626, 2001 | 158 | 2001 |
| Chronic pain and pain processing in Parkinson's disease PJ Blanchet, C Brefel-Courbon Progress in Neuro-Psychopharmacology and Biological Psychiatry 87, 200-206, 2018 | 143 | 2018 |
| Does ageing influence deep brain stimulation outcomes in Parkinson's disease? F Ory‐Magne, C Brefel‐Courbon, M Simonetta‐Moreau, N Fabre, ... Movement disorders: official journal of the Movement Disorder Society 22 (10 …, 2007 | 128 | 2007 |
| Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: A clinical survey in PD patients and age‐matched healthy volunteers JJ Ferreira, K Desboeuf, M Galitzky, C Thalamas, C Brefel‐Courbon, ... European journal of neurology 13 (3), 209-214, 2006 | 118 | 2006 |
